跳至主要内容
临床试验/NCT00951067
NCT00951067撤回不适用

Trial to Compare Pneumatic Compression Treatments for Upper Extremity Acquired Lymphedema

Boston Children's Hospital1 个研究点 分布在 1 个国家开始时间: 2009年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Arm Volume

研究概览

简要总结

The purpose of this study is to determine how well different treatments for acquired lymphedema work.

The study will compare 5 different non-invasive treatments for acquired lymphedema of the arm to see which treats lymphedema best.

详细描述

This study will compare 5 non-invasive lymphedema treatments.

Patients will be assigned to either:

  • A combination of arm exercises, arm elevation, and wearing of a compression garment every day

OR

  • One of four possible pneumatic compression devices for just two hours every day.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients diagnosed with acquired lymphedema of the arm.

排除标准

  • •Refusal of consent
  • •Unlikely compliance with the research protocol
  • •Acute upper extremity DVT

研究组 & 干预措施

Group B

Active Comparator

Pneumatic Compression Device (B)

干预措施: E0650 PCD with non-sequential waveform (Device)

Group A

Active Comparator

Exercise, Elevation, and Garment Compression

干预措施: Exercise, Elevation, and Compression Garment (Other)

Group C

Active Comparator

Pneumatic Compression Device (C)

干预措施: E0651 PCD with sequential, non-gradient waveform (Device)

Group D

Active Comparator

Pneumatic Compression Device (D)

干预措施: E0652 PCD with sequential, gradient waveform (Device)

Group E

Active Comparator

Pneumatic Compression Device (E)

干预措施: E0652 PCD with peristaltic pulse waveform (Device)

结局指标

主要结局

Arm Volume

时间窗: Arm volume will be measured at 2 weeks before treatment starts, day treatment begins, and then 1 month, 3 months, 6 months, and 7 months after treatment starts

次要结局

  • Infection (cellulitis)(Presence of infection will be recorded at 2 weeks before treatment starts, day treatment begins, and then 1 month, 3 months, 6 months, and 7 months after treatment starts)
  • Quality of Life Survey(Survey will be given at 2 weeks before treatment starts, day treatment begins, and then 1 month, 3 months, 6 months, and 7 months after treatment starts)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

终止
不适用
Two Pneumatic Compression Devices in the Treatment of Lower Extremity LymphedemaLymphedema
NCT01239160Tactile Medical238
已完成
不适用
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk StatusLymphedemaBreast Cancer
NCT00383500Stanford University75
终止
不适用
Randomized Clinical Trial of Pneumatic Compression Device for the Treatment of Venous Ulcers and LymphedemaLymphedema
NCT02284373NYU Langone Health39
Unknown
不适用
Standard Compression Therapy With/Without Application of Skin Allograft (Theraskin) for Venous Leg Ulcer TreatmentChronic Venous Hypertension With Ulcer
NCT03935386Solsys Medical LLC100
撤回
不适用
A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After ChemoradiationClinical Stage III HPV-Mediated (p16-pos) Oropharyngeal CarcinomaHead and Neck CarcinomaStage IV Lip and Oral Cavity Cancer AJCC v8Stage III Hypopharyngeal Carcinoma AJCC v8Stage II Lip and Oral Cavity Cancer AJCC v8Stage III Lip and Oral Cavity Cancer AJCC v8Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8Stage II Laryngeal Cancer AJCC v8Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal CarcinomaClinical Stage IV HPV-Mediated (p16-pos)Oropharyngeal CarcinomaStage II Hypopharyngeal Carcinoma AJCC v8Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8Stage III Laryngeal Cancer AJCC v8Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8Stage IV Hypopharyngeal Carcinoma AJCC v8Stage IV Laryngeal Cancer AJCC v8
NCT05512767Mayo Clinic
Pneumatic Compression Treatment For Upper Extremity... | 临床试验